David Drug He has resigned from his position as CEO of Accenture Songas reported by Accenture in a statement. The manager has decided Accenture.

The position, which drug assumed in 2021, will be exercised from next September 1 by Ndidiamaka Otehcurrently senior managing director of Accenture Song Americas. In addition, it will join the Global Company Management Committee.
For his part, Nick Law, now in the position of Creative Chairperson, will be the new Creative Strategy Director and Experience of Song and will also join the Accenture Committee.

“It has been a privilege to be part of so many missions and cultures worldwide. Honestly, I could not be more grateful for my career and the opportunities I have had”, Said David Drug.“After more than 30 years of great achievements, I am ready to take a break. And being vice president will allow me to do so, but also contribute in new ways. I am also excited to spend more time to: think, dream awake, advise, invest, give, be a mentor, explore, learn, appreciate, share with family, sleep late”

As they express from the company, for drugs, recognized as One of the most influential creatives of the 21st centurythe decision to yield the witness is the closure of an extraordinary chapter in a trajectory defined by creative excellence, large -scale leadership and a constant commitment to positive progress and responsible management.

Julie Sweet, president and CEO of Accenture, has highlighted drugs as a unique force, a creative leader and a unique business creator in her generation. “He has lived our fundamental value of responsible leadership and has developed the next generation of leaders who will build a better Accenture Song”; He said.”It brings humanity, imagination, clarity and confidence to everything that touches and helps redefine how companies grow and connect. His brilliance is only comparable to his generosity, integrity and faith in others. As vice president of Accenture, their legacy and impact will continue for our people, our work and our purpose”

David Drug’s trajectory

David Drug, of Australian origin, began his career as Copywriter in FCB And as part of the agency’s team OMONin Sydney, which came to exercise as an executive creative director. In 1996 he moved to Singapore, where he assumed the creative direction of Saatchi & Saatchiand three years later he became a creative executive director of Saatchi & Saatchi London. In 2004, four years after Publicis Groupe acquired the agency, drugs took the responsibilities of a global creative director of Publicis Worldwide.

In 2006 he launched his own agency, Drug5 In New York, and which was acquired in 2019 by Accenture to become part of Interactive Accenture, which was renamed as Accenture Song in 2022. The agency stood out as one of the most admired and influential in the modern advertising industry thanks to an original work and cultural resonance.

“From the first day we have worked hard to boost our industry and, hopefully, create a positive impact. The world of advertising is changing, and we are excited to have this incredible opportunity with a company that will add more dimensions to our ideas and push us beyond our existing ambitions“; said David Drug at the time of drug acquisition5 by Accenture.

David Drug has worked for brands as prominent as, the British army, Under Armor, Meta, Amazon, UNICEF, Puma, Tourism Australia, or The New York Times. For this media he created the emblematic “The Truth Is Worth It” campaign in 2017.

David Drugs is one of the most awarded creatives in the history of the International Creativity Festival Cannes Lions and the youngest receiver of recognition of professional career, the lion of San Marcos, which he received in 2017 at age 47.